Related Experiment Video
Updated: Jun 1, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
MicroRNA-122: a therapeutic target for hepatitis C virus (HCV) infection
Giuseppe Nunnari1, Matthias J Schnell
1Department of Medicine and Medical Specialties, Division of Infectious Diseases, University of Catania, Catania, Italy. gnunnari@hotmail.com
Abstract:
Hepatitis C virus infection is the main cause of liver disease worldwide, often leading to chronic hepatitis. Recent studies have demonstrated that miRNA-122, a liver-specific miRNA, is required for HCV replication in hepatocytes by its binding to the 5' UTR of HCV. Down-regulation of miRNA-122 in vitro and in vivo has led to significant inhibition of viral replication. In the present article, we report the major recent findings on the potential therapeutic role of anti-miRNA-122 molecules.
Related Concept Videos
Hepatitis
MicroRNAs
MicroRNAs
MicroRNAs
Inhibitors of Viral Protein Synthesis
Human Virome

